Global Non-Steroidal Anti-Inflammatory Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Non-Steroidal Anti-Inflammatory Drugs market size was valued at USD 21200 million in 2022 and is forecast to a readjusted size of USD 30080 million by 2029 with a CAGR of 5.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
This report is a detailed and comprehensive analysis for global Non-Steroidal Anti-Inflammatory Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Steroidal Anti-Inflammatory Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-Steroidal Anti-Inflammatory Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-Steroidal Anti-Inflammatory Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-Steroidal Anti-Inflammatory Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Steroidal Anti-Inflammatory Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Steroidal Anti-Inflammatory Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd and Viatris Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-Steroidal Anti-Inflammatory Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Non-Steroidal Anti-Inflammatory Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Steroidal Anti-Inflammatory Drugs, with revenue, gross margin and global market share of Non-Steroidal Anti-Inflammatory Drugs from 2018 to 2023.
Chapter 3, the Non-Steroidal Anti-Inflammatory Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-Steroidal Anti-Inflammatory Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Steroidal Anti-Inflammatory Drugs.
Chapter 13, to describe Non-Steroidal Anti-Inflammatory Drugs research findings and conclusion.
Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
This report is a detailed and comprehensive analysis for global Non-Steroidal Anti-Inflammatory Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Steroidal Anti-Inflammatory Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-Steroidal Anti-Inflammatory Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-Steroidal Anti-Inflammatory Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-Steroidal Anti-Inflammatory Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Steroidal Anti-Inflammatory Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Steroidal Anti-Inflammatory Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd and Viatris Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-Steroidal Anti-Inflammatory Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Non-Selective NSAIDs
- COX-2 Selective NSAIDs
- Dental Pain
- Muscle Aches
- Pain caused by Gout
- Bursitis
- Menstrual Cramps
- Fever
- Others
- Pfizer Inc.
- Bayer AG
- GSK plc
- Dr. Reddy’s Laboratories Ltd
- Viatris Inc
- Teva Pharmaceutical Industries Ltd.
- Johnson And Johnson Services, Inc.
- Merck & Co., Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Non-Steroidal Anti-Inflammatory Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Steroidal Anti-Inflammatory Drugs, with revenue, gross margin and global market share of Non-Steroidal Anti-Inflammatory Drugs from 2018 to 2023.
Chapter 3, the Non-Steroidal Anti-Inflammatory Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-Steroidal Anti-Inflammatory Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Steroidal Anti-Inflammatory Drugs.
Chapter 13, to describe Non-Steroidal Anti-Inflammatory Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-Steroidal Anti-Inflammatory Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Steroidal Anti-Inflammatory Drugs by Type
1.3.1 Overview: Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type in 2022
1.3.3 Non-Selective NSAIDs
1.3.4 COX-2 Selective NSAIDs
1.4 Global Non-Steroidal Anti-Inflammatory Drugs Market by Application
1.4.1 Overview: Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Dental Pain
1.4.3 Muscle Aches
1.4.4 Pain caused by Gout
1.4.5 Bursitis
1.4.6 Menstrual Cramps
1.4.7 Fever
1.4.8 Others
1.5 Global Non-Steroidal Anti-Inflammatory Drugs Market Size & Forecast
1.6 Global Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast by Region
1.6.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region, (2018-2029)
1.6.3 North America Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.1.4 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc. Recent Developments and Future Plans
2.2 Bayer AG
2.2.1 Bayer AG Details
2.2.2 Bayer AG Major Business
2.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.2.4 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bayer AG Recent Developments and Future Plans
2.3 GSK plc
2.3.1 GSK plc Details
2.3.2 GSK plc Major Business
2.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.3.4 GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK plc Recent Developments and Future Plans
2.4 Dr. Reddy’s Laboratories Ltd
2.4.1 Dr. Reddy’s Laboratories Ltd Details
2.4.2 Dr. Reddy’s Laboratories Ltd Major Business
2.4.3 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.4.4 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
2.5 Viatris Inc
2.5.1 Viatris Inc Details
2.5.2 Viatris Inc Major Business
2.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.5.4 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Viatris Inc Recent Developments and Future Plans
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.6.4 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.7 Johnson And Johnson Services, Inc.
2.7.1 Johnson And Johnson Services, Inc. Details
2.7.2 Johnson And Johnson Services, Inc. Major Business
2.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.7.4 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson And Johnson Services, Inc. Recent Developments and Future Plans
2.8 Merck & Co., Inc.
2.8.1 Merck & Co., Inc. Details
2.8.2 Merck & Co., Inc. Major Business
2.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.8.4 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck & Co., Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Steroidal Anti-Inflammatory Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-Steroidal Anti-Inflammatory Drugs by Company Revenue
3.2.2 Top 3 Non-Steroidal Anti-Inflammatory Drugs Players Market Share in 2022
3.2.3 Top 6 Non-Steroidal Anti-Inflammatory Drugs Players Market Share in 2022
3.3 Non-Steroidal Anti-Inflammatory Drugs Market: Overall Company Footprint Analysis
3.3.1 Non-Steroidal Anti-Inflammatory Drugs Market: Region Footprint
3.3.2 Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
3.3.3 Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
6.2 North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
6.3.1 North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
7.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7.3.3 France Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region
8.3.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2029)
8.3.2 China Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.5 India Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
9.2 South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
9.3 South America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
9.3.1 South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
10.3.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-Steroidal Anti-Inflammatory Drugs Market Drivers
11.2 Non-Steroidal Anti-Inflammatory Drugs Market Restraints
11.3 Non-Steroidal Anti-Inflammatory Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Steroidal Anti-Inflammatory Drugs Industry Chain
12.2 Non-Steroidal Anti-Inflammatory Drugs Upstream Analysis
12.3 Non-Steroidal Anti-Inflammatory Drugs Midstream Analysis
12.4 Non-Steroidal Anti-Inflammatory Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Non-Steroidal Anti-Inflammatory Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Steroidal Anti-Inflammatory Drugs by Type
1.3.1 Overview: Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type in 2022
1.3.3 Non-Selective NSAIDs
1.3.4 COX-2 Selective NSAIDs
1.4 Global Non-Steroidal Anti-Inflammatory Drugs Market by Application
1.4.1 Overview: Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Dental Pain
1.4.3 Muscle Aches
1.4.4 Pain caused by Gout
1.4.5 Bursitis
1.4.6 Menstrual Cramps
1.4.7 Fever
1.4.8 Others
1.5 Global Non-Steroidal Anti-Inflammatory Drugs Market Size & Forecast
1.6 Global Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast by Region
1.6.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region, (2018-2029)
1.6.3 North America Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.1.4 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc. Recent Developments and Future Plans
2.2 Bayer AG
2.2.1 Bayer AG Details
2.2.2 Bayer AG Major Business
2.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.2.4 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bayer AG Recent Developments and Future Plans
2.3 GSK plc
2.3.1 GSK plc Details
2.3.2 GSK plc Major Business
2.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.3.4 GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK plc Recent Developments and Future Plans
2.4 Dr. Reddy’s Laboratories Ltd
2.4.1 Dr. Reddy’s Laboratories Ltd Details
2.4.2 Dr. Reddy’s Laboratories Ltd Major Business
2.4.3 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.4.4 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
2.5 Viatris Inc
2.5.1 Viatris Inc Details
2.5.2 Viatris Inc Major Business
2.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.5.4 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Viatris Inc Recent Developments and Future Plans
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.6.4 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.7 Johnson And Johnson Services, Inc.
2.7.1 Johnson And Johnson Services, Inc. Details
2.7.2 Johnson And Johnson Services, Inc. Major Business
2.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.7.4 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson And Johnson Services, Inc. Recent Developments and Future Plans
2.8 Merck & Co., Inc.
2.8.1 Merck & Co., Inc. Details
2.8.2 Merck & Co., Inc. Major Business
2.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
2.8.4 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck & Co., Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Steroidal Anti-Inflammatory Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-Steroidal Anti-Inflammatory Drugs by Company Revenue
3.2.2 Top 3 Non-Steroidal Anti-Inflammatory Drugs Players Market Share in 2022
3.2.3 Top 6 Non-Steroidal Anti-Inflammatory Drugs Players Market Share in 2022
3.3 Non-Steroidal Anti-Inflammatory Drugs Market: Overall Company Footprint Analysis
3.3.1 Non-Steroidal Anti-Inflammatory Drugs Market: Region Footprint
3.3.2 Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
3.3.3 Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
6.2 North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
6.3.1 North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
7.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7.3.3 France Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region
8.3.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2029)
8.3.2 China Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.5 India Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
9.2 South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
9.3 South America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
9.3.1 South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
10.3.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Non-Steroidal Anti-Inflammatory Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-Steroidal Anti-Inflammatory Drugs Market Drivers
11.2 Non-Steroidal Anti-Inflammatory Drugs Market Restraints
11.3 Non-Steroidal Anti-Inflammatory Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Steroidal Anti-Inflammatory Drugs Industry Chain
12.2 Non-Steroidal Anti-Inflammatory Drugs Upstream Analysis
12.3 Non-Steroidal Anti-Inflammatory Drugs Midstream Analysis
12.4 Non-Steroidal Anti-Inflammatory Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 6. Pfizer Inc. Major Business
Table 7. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 8. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Inc. Recent Developments and Future Plans
Table 10. Bayer AG Company Information, Head Office, and Major Competitors
Table 11. Bayer AG Major Business
Table 12. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 13. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bayer AG Recent Developments and Future Plans
Table 15. GSK plc Company Information, Head Office, and Major Competitors
Table 16. GSK plc Major Business
Table 17. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 18. GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. GSK plc Recent Developments and Future Plans
Table 20. Dr. Reddy’s Laboratories Ltd Company Information, Head Office, and Major Competitors
Table 21. Dr. Reddy’s Laboratories Ltd Major Business
Table 22. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 23. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
Table 25. Viatris Inc Company Information, Head Office, and Major Competitors
Table 26. Viatris Inc Major Business
Table 27. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 28. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Viatris Inc Recent Developments and Future Plans
Table 30. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Ltd. Major Business
Table 32. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 33. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 35. Johnson And Johnson Services, Inc. Company Information, Head Office, and Major Competitors
Table 36. Johnson And Johnson Services, Inc. Major Business
Table 37. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 38. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Johnson And Johnson Services, Inc. Recent Developments and Future Plans
Table 40. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 41. Merck & Co., Inc. Major Business
Table 42. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 43. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Merck & Co., Inc. Recent Developments and Future Plans
Table 45. Global Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million) by Players (2018-2023)
Table 46. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Players (2018-2023)
Table 47. Breakdown of Non-Steroidal Anti-Inflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Non-Steroidal Anti-Inflammatory Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key Non-Steroidal Anti-Inflammatory Drugs Players
Table 50. Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
Table 51. Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
Table 52. Non-Steroidal Anti-Inflammatory Drugs New Market Entrants and Barriers to Market Entry
Table 53. Non-Steroidal Anti-Inflammatory Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Share by Type (2018-2023)
Table 56. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Forecast by Type (2024-2029)
Table 57. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023)
Table 58. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Forecast by Application (2024-2029)
Table 59. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 89. Non-Steroidal Anti-Inflammatory Drugs Raw Material
Table 90. Key Suppliers of Non-Steroidal Anti-Inflammatory Drugs Raw Materials
Table 1. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 6. Pfizer Inc. Major Business
Table 7. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 8. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Inc. Recent Developments and Future Plans
Table 10. Bayer AG Company Information, Head Office, and Major Competitors
Table 11. Bayer AG Major Business
Table 12. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 13. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bayer AG Recent Developments and Future Plans
Table 15. GSK plc Company Information, Head Office, and Major Competitors
Table 16. GSK plc Major Business
Table 17. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 18. GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. GSK plc Recent Developments and Future Plans
Table 20. Dr. Reddy’s Laboratories Ltd Company Information, Head Office, and Major Competitors
Table 21. Dr. Reddy’s Laboratories Ltd Major Business
Table 22. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 23. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
Table 25. Viatris Inc Company Information, Head Office, and Major Competitors
Table 26. Viatris Inc Major Business
Table 27. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 28. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Viatris Inc Recent Developments and Future Plans
Table 30. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Ltd. Major Business
Table 32. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 33. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 35. Johnson And Johnson Services, Inc. Company Information, Head Office, and Major Competitors
Table 36. Johnson And Johnson Services, Inc. Major Business
Table 37. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 38. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Johnson And Johnson Services, Inc. Recent Developments and Future Plans
Table 40. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 41. Merck & Co., Inc. Major Business
Table 42. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product and Solutions
Table 43. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Merck & Co., Inc. Recent Developments and Future Plans
Table 45. Global Non-Steroidal Anti-Inflammatory Drugs Revenue (USD Million) by Players (2018-2023)
Table 46. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Players (2018-2023)
Table 47. Breakdown of Non-Steroidal Anti-Inflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Non-Steroidal Anti-Inflammatory Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key Non-Steroidal Anti-Inflammatory Drugs Players
Table 50. Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Type Footprint
Table 51. Non-Steroidal Anti-Inflammatory Drugs Market: Company Product Application Footprint
Table 52. Non-Steroidal Anti-Inflammatory Drugs New Market Entrants and Barriers to Market Entry
Table 53. Non-Steroidal Anti-Inflammatory Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Share by Type (2018-2023)
Table 56. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Forecast by Type (2024-2029)
Table 57. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023)
Table 58. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Forecast by Application (2024-2029)
Table 59. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 89. Non-Steroidal Anti-Inflammatory Drugs Raw Material
Table 90. Key Suppliers of Non-Steroidal Anti-Inflammatory Drugs Raw Materials
LIST OF FIGURES
Figure 1. Non-Steroidal Anti-Inflammatory Drugs Picture
Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type in 2022
Figure 4. Non-Selective NSAIDs
Figure 5. COX-2 Selective NSAIDs
Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application in 2022
Figure 8. Dental Pain Picture
Figure 9. Muscle Aches Picture
Figure 10. Pain caused by Gout Picture
Figure 11. Bursitis Picture
Figure 12. Menstrual Cramps Picture
Figure 13. Fever Picture
Figure 14. Others Picture
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Non-Steroidal Anti-Inflammatory Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Region in 2022
Figure 20. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Players in 2022
Figure 26. Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Non-Steroidal Anti-Inflammatory Drugs Market Share in 2022
Figure 28. Global Top 6 Players Non-Steroidal Anti-Inflammatory Drugs Market Share in 2022
Figure 29. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Share by Type (2018-2023)
Figure 30. Global Non-Steroidal Anti-Inflammatory Drugs Market Share Forecast by Type (2024-2029)
Figure 31. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Share by Application (2018-2023)
Figure 32. Global Non-Steroidal Anti-Inflammatory Drugs Market Share Forecast by Application (2024-2029)
Figure 33. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. France Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Region (2018-2029)
Figure 50. China Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. India Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 67. Non-Steroidal Anti-Inflammatory Drugs Market Drivers
Figure 68. Non-Steroidal Anti-Inflammatory Drugs Market Restraints
Figure 69. Non-Steroidal Anti-Inflammatory Drugs Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Non-Steroidal Anti-Inflammatory Drugs in 2022
Figure 72. Manufacturing Process Analysis of Non-Steroidal Anti-Inflammatory Drugs
Figure 73. Non-Steroidal Anti-Inflammatory Drugs Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Non-Steroidal Anti-Inflammatory Drugs Picture
Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type in 2022
Figure 4. Non-Selective NSAIDs
Figure 5. COX-2 Selective NSAIDs
Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application in 2022
Figure 8. Dental Pain Picture
Figure 9. Muscle Aches Picture
Figure 10. Pain caused by Gout Picture
Figure 11. Bursitis Picture
Figure 12. Menstrual Cramps Picture
Figure 13. Fever Picture
Figure 14. Others Picture
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Non-Steroidal Anti-Inflammatory Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Region in 2022
Figure 20. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Players in 2022
Figure 26. Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Non-Steroidal Anti-Inflammatory Drugs Market Share in 2022
Figure 28. Global Top 6 Players Non-Steroidal Anti-Inflammatory Drugs Market Share in 2022
Figure 29. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Share by Type (2018-2023)
Figure 30. Global Non-Steroidal Anti-Inflammatory Drugs Market Share Forecast by Type (2024-2029)
Figure 31. Global Non-Steroidal Anti-Inflammatory Drugs Consumption Value Share by Application (2018-2023)
Figure 32. Global Non-Steroidal Anti-Inflammatory Drugs Market Share Forecast by Application (2024-2029)
Figure 33. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. France Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Region (2018-2029)
Figure 50. China Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. India Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Non-Steroidal Anti-Inflammatory Drugs Consumption Value (2018-2029) & (USD Million)
Figure 67. Non-Steroidal Anti-Inflammatory Drugs Market Drivers
Figure 68. Non-Steroidal Anti-Inflammatory Drugs Market Restraints
Figure 69. Non-Steroidal Anti-Inflammatory Drugs Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Non-Steroidal Anti-Inflammatory Drugs in 2022
Figure 72. Manufacturing Process Analysis of Non-Steroidal Anti-Inflammatory Drugs
Figure 73. Non-Steroidal Anti-Inflammatory Drugs Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
